PhRMA CEO Selection Day Nears Now That Election Day Has Passed
The Pharmaceutical Research & Manufacturers of America is expected to finalize the succession plan for CEO Alan Holmer during its annual strategy session Nov. 11 and 12
You may also be interested in...
PhRMA's new management team under CEO Billy Tauzin will place a high priority on communications and partnerships with other stakeholders in healthcare policy debates
Rep. Billy Tauzin (R-La.) has suspended discussions with the Pharmaceutical Research & Manufacturers of America to become the trade association's CEO, his office said Feb. 26
Rep. Billy Tauzin's resignation from the chairmanship of the Energy & Commerce Committee paves the way for negotiations to begin in earnest for him to take over as president of the Pharmaceutical Research & Manufacturers of America